Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease

Clinical and Experimental Immunology

Volumn 147, Issue 2, 2007, Pages 287-295

  Nielsen, C H ^a   Hegedus L ^b   Rieneck, K ^c   Moeller, A C ^d   Leslie, R G Q ^d   Bendtzen, K ^a  

^a Copenhagen University Hospital   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c University of Southern Denmark ^*  (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Autoantibodies; Autoimmunity; Cytokines; IL 10; IL 5

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; COMPLEMENT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; THYROGLOBULIN; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ADULT; AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSIVE ELEMENT; DENATURATION; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HEALTH; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; HYPOTHESIS; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SERODIAGNOSIS; TH1 CELL;

ADULT; AUTOANTIGENS; AUTOIMMUNITY; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HEAT; HUMANS; INTERLEUKIN-10; INTERLEUKIN-5; MALE; MIDDLE AGED; PROTEIN DENATURATION; SEX FACTORS; TETANUS TOXOID; TH1 CELLS; THYROGLOBULIN;

EID: 33846204725     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03283.x     Document Type: Article

References (39)

1. Del Prete GF, Tiri A, De Carli M et al. High potential to tumor necrosis factor (TNF-) production of thyroid infiltrating lymphocytes in Hashimoto's thyroiditis: a peculiar feature of destructive thyroid autoimmunity. Autoimmunity 1989; 4:267-76.
2. Del Prete GF, Tiri A, Mariotti S, Pinchera A, Ricci M, Romagnani S. Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis. Clin Exp Immunol 1987; 69:323-31.
3. Guo J, Rapoport B, McLachlan SM. Balance of Th1/Th2 cytokines in thyroid autoantibody synthesis in vitro. Autoimmunity 1999; 30:1-9.
4. Ajjan RA, Watson PF, McIntosh RS, Weetman AP. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol 1996; 105:523-8.
5. Watson PF, Pickerill AP, Davies R, Weetman AP. Analysis of cytokine gene-expression in Graves-disease and multinodular goiter. J Clin Endocrinol Metab 1994; 79:355-60.
6. Nagayama YJ, Mizuguchi H,Hayakawa T, Niwa M, McLachlan SM, Rapoport B. Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine. J Immunol 2003; 170:3522-7.
7. Fox CJ, Danska JS. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J Immunol 1997; 158:2414-24.
8. Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in non-obese diabetic (NOD) mice. J Exp Med 1996; 184:1093-9.
9. Seddon B, Mason D. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+) CD45RC(-) cells and CD4(+) CD8(-) thymocytes. J Exp Med 1999; 189:279-88.
10. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001; 182:68-79.
11. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3:944-50.
12. Byrne A, Reen DJ. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J Immunol 2002; 168:1968-77.
13. Wen XS, Zhang DQ, Kikuchi Y et al. Transgene-mediated hyperexpression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus. Eur J Immunol 2004; 34:2740-9.
14. Moore KW, Malefyt RD, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
15. Takeoka K, Watanabe M, Matsuzuka F, Miyauchi A, Iwatani Y. Increase of serum interleukin-10 in intractable Graves' disease. Thyroid 2004; 14:201-5.
16. Nakamoto Y, Niki M, Watanabe M, Iwatani Y. Increase in immunoglobulin G3-secreting cells in intractable Graves' disease. Thyroid 2003; 13:325-31.
17. Weetman AP. Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol 2004; 61:405-13.
18. Wogensen L, Lee MS, Sarvetnick N. Production of interleukin-10 by islet cells accelerates immune-mediated destruction of beta-cells in nonobese diabetic mice. J Exp Med 1994; 179:1379-84.
19. Zaccone P, Fehervari Z, Blanchard L, Nicoletti F, Edwards CK, Cooke A. Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type 1. Eur J Immunol 2002; 32:1021-8.
20. Yip HC, Karulin AY, Tary-Lehmann M et al. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol 1999; 162:3942-9.
21. Nielsen CH, Hegedus L, Leslie RG. Autoantibodies in autoimmune thyroid disease promote immune complex formation with self antigens and increase B cell and CD4+ T cell proliferation in response to self antigens. Eur J Immunol 2004; 34:263-72.
22. Nielsen CH, Leslie RG, Jepsen BS, Kazatchkine MD, Kaveri SV, Fischer E. Natural autoantibodies and complement promote the uptake of a self antigen, human thyroglobulin, by B cells and the proliferation of thyroglobulin-reactive CD4(+) T cells in healthy individuals. Eur J Immunol 2001; 31:2660-8.
23. Francis T, Burch HB, Cai WY et al. Lymphocytes express thyrotropin receptor-specific mRNA as detected by the PCR technique. Thyroid 1991; 1:223-8.
24. Wang HC, Dragoo J, Zhou Q, Klein JR. An intrinsic thyrotropin-mediated pathway of TNF-alpha production by bone marrow cells. Blood 2003; 101:119-23.
25. De la Vega JR, Vilaplana JC, Biro A, Hammond L, Bottazzo GF, Mirakian R. IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity? Clin Exp Immunol 1998; 113:126-35.
26. Finkelman FD, Holmes J, Katona IM et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8:303-33.
27. Skapenko A, Niedobitek GU, Kalden JR, Lipsky PE, Schulze-Koops H. Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10. J Immunol 2004; 172:6427-34.
28. Joosten LAB, Lubberts E, Durez P et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis - protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997; 40:249-60.
29. Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL. Interleukin-10 expression and chemokine regulation during the evolution of murine type-II collagen-induced arthritis. J Clin Invest 1995; 95:2868-76.
30. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992; 79:3101-9.
31. Hitoshi Y, Yamaguchi N, Mita S et al. Distribution of IL-5 receptor-positive B cells - expression of IL-5 receptor on Ly-1 (CD5)+ B cells. J Immunol 1990; 144:4218-25.
32. Tominaga A, Takaki S, Koyama N et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin-5) develop eosinophilia and autoantibody production. J Exp Med 1991; 173:429-37.
33. Shirai T, Hirose S, Okada T, Nishimura H. CD5+ B cells in autoimmune disease and lymphoid malignancy. Clin Immunol Immunopathol 1991; 59:173-86.
34. Tian JD, Atkinson MA, ClareSalzler M et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996; 183:1561-7.
35. Chen M, Gran B, Costello K, Johnson K, Martin R, Dhib-Jalbut S. Glatiramer acetate induces a Th2-biased response and cross-reactivity with myelin basic protein in patients with MS. Multiple Sclerosis 2001; 7:209-19.
36. Jacquier-Sarlin MR, Gabert FM, Villiers MB, Colomb MG. Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 1995; 84:164-70.
37. Jiang K, Chen Y, Xu CS, Jarvis JN. T cell activation by soluble C1q-bearing immune complexes: implications for the pathogenesis of rheumatoid arthritis. Clin Exp Immunol 2003; 131:61-7.
38. Wagner C, Hansch GM, Stegmaier S, Denefleh B, Hug F, Schoels M. The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory function. Eur J Immunol 2001; 31:1173-80.
39. Nielsen CH, Antonsen S, Matthiesen SH, Leslie RGQ. The roles of complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) in the regulation of the immune complex-elicited respiratory burst of polymorphonuclear leukocytes in whole blood. Eur J Immunol 1997; 27:2914-9.